Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Withus Pharmaceutical Co. Ltd. (330350:KRX), powered by AI.
Withus Pharmaceutical Co. Ltd. is currently trading at ₩8,180. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Withus Pharmaceutical Co. Ltd. on Alpha Lenz.
Withus Pharmaceutical Co. Ltd.'s P/E ratio is 21.7.
“Withus Pharmaceutical Co. Ltd. trades at a P/E of 21.7 (fair value) with modest ROE of 5.2%. 3Y revenue CAGR of 18.1% highlights clear growth momentum.”
Ask for details →Withus Pharmaceutical Co. Ltd. is a dynamic entity in the healthcare sector, primarily focusing on the development and production of pharmaceuticals and healthcare products. As a key player in the market, the company is actively engaged in research and development to bring innovative and effective therapeutic solutions to a broad spectrum of medical needs. Its product line spans various therapeutic areas, emphasizing quality and reliability, and is distributed across numerous channels including hospitals, pharmacies, and direct-to-consumer sales. With a commitment to enhancing health outcomes, Withus Pharmaceutical Co. Ltd. contributes significantly to the pharmaceutical industry's advancement. The company maintains stringent standards in its manufacturing processes and actively collaborates with healthcare professionals and institutions to ensure its products meet the highest safety and efficacy benchmarks. With its strategic positioning and continuous innovation, Withus Pharmaceutical Co. Ltd. plays a crucial role in the healthcare ecosystem, addressing the evolving challenges and demands of modern medicine.
“Withus Pharmaceutical Co. Ltd. trades at a P/E of 21.7 (fair value) with modest ROE of 5.2%. 3Y revenue CAGR of 18.1% highlights clear growth momentum.”
Ask for details →Withus Pharmaceutical Co. Ltd. (ticker: 330350) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $108.0B.
The current price is ₩8,180 with a P/E ratio of 21.74x and P/B of 1.1x.
ROE is 5.20% and operating margin is 5.32%. Annual revenue is $106.4B.